[SCHEDULE 13G/A Amendment No. 15 Global Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) G39342103 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *]
[SCHEDULE 13G/A Amendment No. 15 Global Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) G39342103 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *]
[FORM 6-K/A (Amendment No. 1) For the month of December 2019 GLOBAL CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower Hong Kong S.A.R. Form 20-F x o o o Yes o x EXPLANATORY NOTE 2 3 Results of Operations and Financial Condition]
[FORM 6-K/A (Amendment No. 1) For the month of December 2019 GLOBAL CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower Hong Kong S.A.R. Form 20-F x o o o Yes o x EXPLANATORY NOTE 2 3 Results of Operations and Financial Condition]
[Global Cord Blood Corporation Announces Results of 201 9 Annual General Meeting HONG KONG, China, December 5 , 201 9 - Global Cord Blood Corporation At the Annual General Meeting, shareholders · · About Global Cord Blood Corporation Global Cord Blood Corporation is the first and largest umbilical co]
[Global Cord Blood Corporation Announces Results of 201 9 Annual General Meeting HONG KONG, China, December 5 , 201 9 - Global Cord Blood Corporation At the Annual General Meeting, shareholders · · About Global Cord Blood Corporation Global Cord Blood Corporation is the first and largest umbilical co]
[Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2020 2Q20 Added 21,551 New Subscribers Revenues Up 26.9% YoY to RMB313.5 Million ($43.9 Million) Operating Income Up 37.9% YoY to RMB144.4 Million ($20.2 Million) Non-GAAP Operating Income Up 32.8]
[Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2020 2Q20 Added 21,551 New Subscribers Revenues Up 26.9% YoY to RMB313.5 Million ($43.9 Million) Operating Income Up 37.9% YoY to RMB144.4 Million ($20.2 Million) Non-GAAP Operating Income Up 32.8]
[GLOBAL CORD BLOOD CORPORATION (Incorporated in the Cayman Islands with limited liability) 48 th NOTICE OF ANNUAL GENERAL MEETING to Be Held on December 5, 2019 To the Shareholders of Global Cord Blood Corporation: NOTICE IS HEREBY GIVEN that th To table the financial statements of the Company for th]
[GLOBAL CORD BLOOD CORPORATION (Incorporated in the Cayman Islands with limited liability) 48 th NOTICE OF ANNUAL GENERAL MEETING to Be Held on December 5, 2019 To the Shareholders of Global Cord Blood Corporation: NOTICE IS HEREBY GIVEN that th To table the financial statements of the Company for th]
